EURON and THEME joint PhD meeting
EURON and THEME joint PhD meeting
EURON and THEME joint PhD meeting
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
99<br />
<strong>EURON</strong> <strong>and</strong> <strong>THEME</strong> <strong>joint</strong> <strong>meeting</strong> 2011<br />
Brain-derived neurotrophic factor (BDNF), a bridge<br />
between depression <strong>and</strong> Alzheimer’s disease<br />
Tim Vanmierlo, Jochen De Vry, Caroline Hammels, Annerieke Sierksma, Denise<br />
Hermes, Harry Steinbusch <strong>and</strong> Jos Prickaerts.<br />
School for Mental Health <strong>and</strong> Neuroscience, Maastricht University, Maastricht, The Netherl<strong>and</strong>s<br />
There is ample evidence suggesting that a history of major depression constitutes a<br />
risk factor for the development of Alzheimer’s disease (AD) later in life. Decreased<br />
levels of the growth factor brain-derived neurotrophic factor (BDNF) play a key<br />
role in the reduced plasticity in the hippocampus of patients with depression as<br />
well as in patients with AD. We hypothesize that hippocampal overexpression<br />
of tropomyosine receptor kinase (TrkB), the high affinity receptor of BDNF, will<br />
attenuate <strong>and</strong> delay the onset of AD pathology. To test this hypothesis we used<br />
the APPswe/PS1dE9 mouse model of AD. Hippocampal TrkB overexpression<br />
was established via a current controlled stereotactic microelectroporation of a<br />
plasmid stably expressing TrkB at the start of AD pathology, i.e. plaques formation,<br />
at 6 months of age. Memory was scored at 7 months of age, when cognitive<br />
decline is expected to start, in the object location task, the Morris water escape<br />
maze <strong>and</strong> the spatial alteration Y-maze. In addition, depression <strong>and</strong> anxiety<br />
related behavior were respectively assessed in the sucrose preference test, the<br />
forced swim task <strong>and</strong> the elevated zero maze. Electroporation efficiency will be<br />
validated by immunohistochemistry (IHC). Manifestation of the AD pathology<br />
on the molecular level will be quantified by ELISA <strong>and</strong> IHC. First results showed<br />
surprisingly that TrkB overexpression in the hippocampus impaired object location<br />
memory in our AD mice. In contrast, depression–like behavior in the forced swim<br />
test was attenuated in these AD mice. No effects of TrkB overexpression were<br />
observed in wild-type control mice. Biochemical <strong>and</strong> IHC analyses are underway<br />
to further investigate this possible TrkB-mediated distinction in cognitive <strong>and</strong><br />
affective behavior in AD mice.